Vertex Pharmaceuticals, Inc. (VRTX)
444.55
+7.54
(+1.73%)
USD |
NASDAQ |
Dec 10, 16:00
445.50
+0.95
(+0.21%)
After-Hours: 20:00
Vertex Pharmaceuticals Free Cash Flow: 3.337B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Amgen, Inc. | 11.54B |
| Eli Lilly & Co. | 6.436B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.241B |
| Cash from Investing (Quarterly) | -117.00M |
| Cash from Financing (Quarterly) | -1.154B |
| Free Cash Flow Per Share (Quarterly) | 4.424 |
| Free Cash Flow to Equity (Quarterly) | 832.20M |
| Free Cash Flow to Firm (Quarterly) | 1.142B |
| Free Cash Flow Yield | 2.90% |